Immunocore claims first-ever FDA approval for TCR cancer the...

Immunocore has secured a piece of biotech industry history, becoming the first company to get an FDA approval for a cancer therapeutic based on T cell receptor (TCR) technology.

6th CAR-TCR Summit 2021

6th CAR-TCR Summit - Aug 30 - Sep 2, 2021

2nd TCR-based Therapies Summit

Development of next-generation TCR-T products

GSK begins cancer cell therapy tie-up with Immatics

Cancer biotech Immatics has begun a collaboration with GlaxoSmithKline to develop novel therapies built around its T-cell-based technology.

Change at the top at Adaptimmune as Noble stands down

Kite outlines vision for next gen cancer killing cells

Backed by Amgen, Kite outlines bold plan for developing CAR-T and TCR cells.